ELUTElutia Inc.

ELUT Stock Price, Valuation & Chart | Elutia Inc.

Compare

$0.870+0.01 (+1.30%)

At close · 02 Sept 2026, 07:59 pm

Sector: Healthcare Industry: Biotechnology ELUT intrinsic value ELUT calculated fair value vs price

Overview Financials Dividends Ratios

ELUT Historical price chart

ELUT Key Stats

Fair Value

Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Unlock

Market Capitalization38.56M

PE Ratio-1.78

EPS-0.49

Trading Volume9.34K

Today's High/Low0.94/0.84

Dividend Yield0.00

52 Week High/Low2.13/0.5

Shares Outstanding44.21M

ELUT Financial Statement

ELUT Analyst ratings

ELUT Analysis & performance metrics

ELUT Company profile

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United…

Elutia Inc., a commercial-stage company, develops and commercializes drug-eluting biologics products for neurostimulation, wound care, and breast reconstruction in the United States. The company operates in three segments: Device Protection; Women's Health; and Cardiovascular. It offers CanGaroo Envelope, which is used to accommodate cardiac implantable electronic devices, such as…

ELUT Management team

Name

Position

Dwayne Montgomery

Head of Cardiovascular

Matthew B. FergusonCFO

Chief Financial Officer

Jeffry D. Hamet

Senior Vice President of Finance, Treasurer & Secretary

Courtney Guyer

Vice President of Marketing

C. Randal Mills Ph.D.CEO

Co-Founder, President, Chief Executive Officer & Director

Michelle LeRoux Williams Ph.D.

Chief Scientific Officer

Sonali Fonseca Ph.D.

Vice President & Head of Emerging Businesses

Name

Position

Dwayne Montgomery

Head of Cardiovascular

Matthew B. FergusonCFO

Chief Financial Officer

Jeffry D. Hamet

Senior Vice President of Finance, Treasurer & Secretary

Courtney Guyer

Vice President of Marketing

C. Randal Mills Ph.D.CEO

Co-Founder, President, Chief Executive Officer & Director

Michelle LeRoux Williams Ph.D.

Chief Scientific Officer

Sonali Fonseca Ph.D.

Vice President & Head of Emerging Businesses

Management Team

Dwayne Montgomery

Head of Cardiovascular

Matthew B. FergusonCFO

Chief Financial Officer

Jeffry D. Hamet

Senior Vice President of Finance, Treasurer & Secretary

Courtney Guyer

Vice President of Marketing

C. Randal Mills Ph.D.CEO

Co-Founder, President, Chief Executive Officer & Director

Michelle LeRoux Williams Ph.D.

Chief Scientific Officer

Sonali Fonseca Ph.D.

Vice President & Head of Emerging Businesses

Management

Dwayne Montgomery

Head of Cardiovascular

Matthew B. FergusonCFO

Chief Financial Officer

Jeffry D. Hamet

Senior Vice President of Finance, Treasurer & Secretary

Courtney Guyer

Vice President of Marketing

C. Randal Mills Ph.D.CEO

Co-Founder, President, Chief Executive Officer & Director

Michelle LeRoux Williams Ph.D.

Chief Scientific Officer

Sonali Fonseca Ph.D.

Vice President & Head of Emerging Businesses

Total 7 executives

ELUT Frequently asked questions

What is Elutia Inc. (ELUT) Stock Price?

Current stock price of Elutia Inc. (ELUT) stock is $0.870. The stock price is +1.30% higher in the session. The intraday range can be seen from this page. Volume of Elutia Inc. (ELUT) stock is 9.34K.

Last updated at 02 Sept 2026, 07:59 pm.

Why is the Elutia Inc. (ELUT) stock price going up or down today?

The stock price of Elutia Inc. (ELUT) can change with earnings, company news, and overall market sentiment. Elutia Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Elutia Inc. stock expensive at its current price?

Whether Elutia Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for ELUT on this page is -1.78. EPS on this page is -0.49. Compare those figures with peers and growth expectations before deciding if the current Elutia Inc. price is justified.

How has the stock price of Elutia Inc. (ELUT) performed historically?

Historical performance for Elutia Inc. (ELUT) is shown on the price chart on this page. Review multi-period moves alongside volume to see how ELUT reacted to past earnings and market events.

Should I buy Elutia Inc. (ELUT) stock, at this price?

Buying Elutia Inc. (ELUT) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.